Literature DB >> 1757964

Arginine 109 to glutamine mutation in a girl with ornithine carbamoyl transferase deficiency.

S Strautnieks1, P Rutland, S Malcolm.   

Abstract

We studied DNA from 29 families with at least one member with ornithine carbamoyl transferase (OCT) deficiency and have found a mutation in the TaqI site within exon 5 of the OCT gene in a female presenting at the age of 21 months. Hybridisation with site specific oligonucleotides shows that the mutation is a C to T substitution resulting in a glutamine for arginine substitution at amino acid 109.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757964      PMCID: PMC1017166          DOI: 10.1136/jmg.28.12.871

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Mosaicism for an intragenic deletion in a boy with mild ornithine transcarbamylase deficiency.

Authors:  A Maddalena; D M Sosnoski; G T Berry; R L Nussbaum
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

2.  CpG dinucleotides are mutation hot spots in phenylketonuria.

Authors:  V Abadie; S Lyonnet; N Maurin; M Berthelon; C Caillaud; F Giraud; J F Mattei; J Rey; F Rey; A Munnich
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  A rapid method for the purification of DNA from blood.

Authors:  M Jeanpierre
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

4.  Scanning detection of mutations in human ornithine transcarbamoylase by chemical mismatch cleavage.

Authors:  M Grompe; D M Muzny; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.

Authors:  R Rozen; J Fox; W A Fenton; A L Horwich; L E Rosenberg
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

6.  An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells.

Authors:  J T Lee; R L Nussbaum
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Use of denaturing gradient gel electrophoresis for detection of mutation and prospective diagnosis in late onset ornithine transcarbamylase deficiency.

Authors:  J E Finkelstein; C A Francomano; S W Brusilow; M D Traystman
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

8.  Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency.

Authors:  A Maddalena; J E Spence; W E O'Brien; R L Nussbaum
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Ornithine transcarbamylase deficiency resulting from a C-to-T substitution in exon 5 of the ornithine transcarbamylase gene.

Authors:  A Hata; C Setoyama; K Shimada; E Takeda; Y Kuroda; I Akaboshi; I Matsuda
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

10.  Molecular pathology of haemophilia B.

Authors:  P M Green; D R Bentley; R S Mibashan; I M Nilsson; F Giannelli
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more
  3 in total

1.  Identification of four novel splice site mutations in the ornithine transcarbamylase gene.

Authors:  E Oppliger Leibundgut; B Wermuth; J P Colombo; S Liechti-Gallati
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

2.  Expression of four mutant human ornithine transcarbamylase genes in cultured Cos 1 cells relates to clinical phenotypes.

Authors:  T Matsuura; R Hoshide; C Setoyama; S Komaki; K Kiwaki; F Endo; S Nishikawa; I Matsuda
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

3.  Ornithine transcarbamylase deficiency: new sites with increased probability of mutation.

Authors:  E O Oppliger Leibundgut; S Liechti-Gallati; J P Colombo; B Wermuth
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.